CHEBI:233318 - FHD-286

ChEBI IDCHEBI:233318
ChEBI NameFHD-286
Stars
DefinitionFHD-286 is a selective, oral inhibitor of SMARCA4/SMARCA2 ATPase (BRG1 and BRM) inhibitor. FHD-286 has the potential for the research of BAF (BRG1/BRM-associated factor)-related disorders such as acute myeloid leukemia.
Submitterlbonaobra
DownloadsMolfile
FormulaC24H30N6O6S2
Net Charge0
Average Mass562.674
Monoisotopic Mass562.16682
SMILESCOC[C@H](NC(=O)c1ccn(S(C)(=O)=O)c1)C(=O)Nc1nc(-c2cccc(N3C[C@@H](C)O[C@@H](C)C3)n2)cs1
InChIInChI=1S/C24H30N6O6S2/c1-15-10-29(11-16(2)36-15)21-7-5-6-18(25-21)20-14-37-24(27-20)28-23(32)19(13-35-3)26-22(31)17-8-9-30(12-17)38(4,33)34/h5-9,12,14-16,19H,10-11,13H2,1-4H3,(H,26,31)(H,27,28,32)/t15-,16+,19-/m0/s1
InChIKeyJBLQNFBXKOAIHG-FCEWJHQRSA-N
ChEBI Ontology
Outgoing Relation(s)
FHD-286 (CHEBI:233318) is a organic molecular entity (CHEBI:50860)
Synonyms  Source
2671128-05-3SUBMITTER
CamibirstatSUBMITTER
N-((S)-1-((4-(6-((2S,6R)-2,6-dimethylmorpholino)pyridin-2-yl)thiazol-2-yl)amino)-3-methoxy-1-oxopropan-2-yl)-1-(methylsulfonyl)-1H-pyrrole-3-carboxamideSUBMITTER
Registry NumbersSources
CAS:2671128-05-3SUBMITTER